CYP2B6rs2279343 Is Associated with Improved Survival of Pediatric Rhabdomyosarcoma Treated with Cyclophosphamide.
Saved in:
| Title: | CYP2B6rs2279343 Is Associated with Improved Survival of Pediatric Rhabdomyosarcoma Treated with Cyclophosphamide. |
|---|---|
| Authors: | Labib RM; Research Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt.; Clinical Pharmacy, Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt., A Abdelrahim ME; Clinical Pharmacy, Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt., Elnadi E; Pediatric Oncology Department, Beni-Suef University Faculty of medicine, Beni-Suef, Egypt.; Pediatric Oncology Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt., Hesham RM; Biochemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt., Yassin D; Molecular Biology Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt. |
| Source: | PloS one [PLoS One] 2016 Jul 07; Vol. 11 (7), pp. e0158890. Date of Electronic Publication: 2016 Jul 07 (Print Publication: 2016). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0158890 |
